MacroGenics Inc.

MGNX | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.12

-$0.02 (-0.48%)

At close: Sep 21, 2026, 4:00 PM ET

$4.13

+$0.01 (+0.24%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.48%

(1D)

Rating

Updated: Sep 18, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $261.88M

1D Range

4.09 4.19

52W Range

1.29 5.08

Valuation (TTM)

PE -18.73

PB 6.11

EV/EBITDA -3.98

Valuation (NTM)

Forward PE N/A

Forward PEG 2.72

Price Target $6

Cash Flow

FCF Yield -25.0%

SBC Adj. FCF Yield -29.2%

SBC Impact -16.5%

Margins

Gross Margin 50.4%

Operating Margin -24.3%

FCF Margin -39.1%

Growth (CAGR)

Revenue 3Y | 5Y 3.2% | 7.3%

Dil EPS 3Y | 5Y 99.2% | 46.7%

FCF 3Y | 5Y 46.2% | 16.3%

Returns

ROA -4.2%

ROE -31.3%

ROIC -2.4%

Financial Health

Net Cash

$138.21M

Current Ratio 2.96

Interest Coverage -2.41

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The c...

Sector Healthcare

Industry Biotechnology

Employees 293

IPO Date Oct 9, 2013

Website www.macrogenics.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 11, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+45.63%

Buy (2)

Hold (1)

Sell (0)

Analyst Details ➞